AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
26min chapter
T-Cells For The Win With Adaptimmune's Adrian Rawcliffe
Business Of Biotech
Navigating Biologics and Cell Therapy Advancements
This chapter examines the shift from traditional small molecule drugs to biologics, highlighting their clinical advantages and the challenges entrenched practitioners face. It explores the intricacies of biotechnology, focusing on the strategic development of in-house T-cell manufacturing capabilities and the financial considerations behind this transition. Additionally, the chapter addresses the importance of logistics and dedicated business models in commercializing cell therapies within the evolving biopharmaceutical landscape.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode